Cancer patients undergoing chemotherapy are the primary beneficiaries of dolasetron. It is especially useful for those receiving highly emetogenic (causing vomiting) chemotherapy regimens. It can also be used in patients undergoing radiation therapy or surgical procedures that may induce nausea and vomiting.
